About This Study
Amyotrophic Lateral Sclerosis (ALS) is a disease that slowly makes it harder for your brain to talk to your muscles, causing weakness and trouble moving. The purpose of this study is to learn more about a new treatment for this disease called VHB937. We want to see if this treatment can safely slow down the disease among patients with early-stage ALS.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- After Study Follow-Up Activities
- Review of Medical History
- Physical Examinations
- Phone Calls and/or Emails
- Study Visits and Consultations
- Surveys/Questionnaires
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 18 - 100+ years old
- All Genders
Language
- This study enrolls English and Spanish speakers
Additional Study Information
- No compensation provided
- Reimbursement offered
Study Locations
- Greater Charlotte, NC